DK136900C - Analogifremgangsmaade til fremstilling af usymmetriske 1,4-dihydropyridindicarboxylsyreestere - Google Patents

Analogifremgangsmaade til fremstilling af usymmetriske 1,4-dihydropyridindicarboxylsyreestere

Info

Publication number
DK136900C
DK136900C DK118573A DK118573A DK136900C DK 136900 C DK136900 C DK 136900C DK 118573 A DK118573 A DK 118573A DK 118573 A DK118573 A DK 118573A DK 136900 C DK136900 C DK 136900C
Authority
DK
Denmark
Prior art keywords
unusymmetric
dihydropyridin
preparing
dicarboxylic acid
acid esters
Prior art date
Application number
DK118573A
Other languages
Danish (da)
English (en)
Other versions
DK136900B (da
Inventor
H Meyer
F Bossert
W Vater
K Stoepel
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of DK136900B publication Critical patent/DK136900B/da
Application granted granted Critical
Publication of DK136900C publication Critical patent/DK136900C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK118573A 1972-03-06 1973-03-05 Analogifremgangsmaade til fremstilling af usymmetriske 1,4-dihydropyridindicarboxylsyreestere DK136900C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2210672A DE2210672C3 (de) 1972-03-06 1972-03-06 N-substituierte unsymmetrische 1 ^-Dihydropyridin-S^-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel

Publications (2)

Publication Number Publication Date
DK136900B DK136900B (da) 1977-12-12
DK136900C true DK136900C (da) 1978-05-22

Family

ID=5838025

Family Applications (1)

Application Number Title Priority Date Filing Date
DK118573A DK136900C (da) 1972-03-06 1973-03-05 Analogifremgangsmaade til fremstilling af usymmetriske 1,4-dihydropyridindicarboxylsyreestere

Country Status (25)

Country Link
US (1) US3883540A (ja)
JP (1) JPS5626657B2 (ja)
KR (1) KR780000010B1 (ja)
AT (1) AT324335B (ja)
AU (1) AU468879B2 (ja)
BE (1) BE796274A (ja)
BG (2) BG20351A3 (ja)
CA (1) CA1045138A (ja)
CH (2) CH578530A5 (ja)
CS (2) CS173649B2 (ja)
DD (1) DD107456A5 (ja)
DE (1) DE2210672C3 (ja)
DK (1) DK136900C (ja)
ES (2) ES412319A1 (ja)
FR (1) FR2183674B1 (ja)
GB (1) GB1384031A (ja)
HU (1) HU164867B (ja)
IE (1) IE37366B1 (ja)
IL (1) IL41668A (ja)
LU (1) LU67146A1 (ja)
NL (1) NL7303135A (ja)
PL (2) PL89257B1 (ja)
RO (2) RO63067A (ja)
SU (6) SU464111A3 (ja)
ZA (1) ZA731500B (ja)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4031104A (en) * 1972-04-18 1977-06-21 Bayer Aktiengesellschaft 1,4-Dihydropyridine carboxylic acid esters
US3974278A (en) * 1973-07-12 1976-08-10 Bayer Aktiengesellschaft 1,4-Dihydropyridine esters
CH607848A5 (ja) * 1974-06-04 1978-11-30 Bayer Ag
FR2320750A1 (fr) * 1975-08-12 1977-03-11 Hexachimie Dihydro-1,4 pyridines et leur application therapeutique
US4466972A (en) * 1977-06-20 1984-08-21 Sandoz Ltd. Benzoxadiazoles and benzothiadiazoles, their preparation and pharmaceutical compositions containing them
SU798099A1 (ru) * 1978-03-06 1981-01-23 Ордена Трудового Красного Знамениинститут Органического Синтезаан Латвийской Ccp 1-Бензил-2,6-диметил-4-о-или-M-НиТРОфЕНил-3,5-диэТОКСиКАРбОНил- 1,4-дигидРОпиРидиНы, пРО Вл ющиЕКОРОНАРОдилАТиРующую АКТиВНОСТь
SE429652B (sv) * 1978-06-30 1983-09-19 Haessle Ab 2.6-dimetyl-4-(2.3-diklorfenyl)-1.4-dihydropyridin-3.5-dikarboxylsyra-3-metylester-5-etylester
DE2847236A1 (de) * 1978-10-31 1980-05-14 Bayer Ag Neue dihydropyridine mit substituierten estergruppierungen, mehrer verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4497808A (en) * 1981-12-30 1985-02-05 Ciba-Geigy Corporation N-Oxide compounds useful in the treatment of cardiovascular ailments
DE3208628A1 (de) * 1982-03-10 1983-09-22 Bayer Ag, 5090 Leverkusen Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
IL68604A0 (en) * 1982-05-21 1983-09-30 Haessle Ab Processes for preparing therapeutically active dihydropyridines and intermediates for the processes
DE3312283A1 (de) * 1983-04-05 1984-10-18 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von unsymmetrischen 1,4-dihydropyridincarbonsaeureestern
US5237089A (en) * 1986-02-07 1993-08-17 Basf Aktiengesellschaft Nitro or amino substituted phenylalkyl or phenylalkenyl carboxylic acid derivatives
DE3724399A1 (de) * 1987-07-23 1989-02-02 Basf Ag Phenylalkenylcarbonsaeuren und deren ester
US5216172A (en) * 1988-02-24 1993-06-01 Ajinomoto Co., Inc. 1,4-dihydropyridine-4-aryl-2,6-dimethyl-3,5-dicarboxylates useful as agents against drug resistant tumor cells
EP0330470A3 (en) * 1988-02-24 1992-01-02 Ajinomoto Co., Inc. 1,4-dihydropyridine derivatives useful against tumour cells
DE4011695A1 (de) * 1990-04-11 1991-10-17 Bayer Ag Verwendung von n-alkylierten 1,4-dihydropyridindicarbonsaeureestern als arzneimittel, neue verbindungen und verfahren zu ihrer herstellung
DE4125271A1 (de) * 1991-07-31 1993-02-11 Bayer Ag Neue n-alkylierte 1,4-dihydropyridindicarbonsaeureester
DE4133257A1 (de) * 1991-10-08 1993-04-15 Bayer Ag N-methyl-nimodipin, verfahren zu seiner herstellung und seine verwendung als zerebraltherapeutikum
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
CN103259027A (zh) 2005-04-28 2013-08-21 普罗透斯数字保健公司 药物信息系统
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(ｒａｐ)-접합체 투여에 의한 간 질환의 치료
PT2398500T (pt) 2009-02-20 2019-06-14 2 Bbb Medicines B V Sistema de entrega de medicamentos à base de glutationas
TWI556839B (zh) 2009-05-06 2016-11-11 研究室護膚股份有限公司 包含活性劑－磷酸鈣粒子複合物之皮膚遞送組成物及其使用方法
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN110606822A (zh) * 2011-11-24 2019-12-24 里克特吉迪翁公司 具有hsp调节活性的1,4-二氢吡啶衍生物
JP7411994B2 (ja) 2020-03-19 2024-01-12 昌史 星野 腰枕および腰枕セット

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2359329A (en) * 1943-06-18 1944-10-03 Burroughs Wellcome Co Quinoline substituted dihydropyridines
DE2013431C3 (de) * 1970-03-20 1979-12-20 Bayer Ag, 5090 Leverkusen 4-Azidophenyl-l,4-dihydropyridin-3,5-dicarbonsäureester
DE1963186C3 (de) * 1969-12-17 1979-02-15 Bayer Ag, 5090 Leverkusen Schwefelhaltige 1,4-Dihydropyridin-33-dicarbonsäureester
DE2117572C3 (de) * 1971-04-10 1980-03-20 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin ^-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
IE37366L (en) 1973-09-06
BG22389A3 (bg) 1977-02-20
BE796274A (fr) 1973-09-05
CH578530A5 (ja) 1976-08-13
JPS5626657B2 (ja) 1981-06-19
RO63067A (fr) 1978-05-15
CS173624B2 (ja) 1977-02-28
IL41668A0 (en) 1973-05-31
DE2210672A1 (de) 1973-09-20
LU67146A1 (ja) 1973-05-22
HU164867B (ja) 1974-05-28
FR2183674B1 (ja) 1976-10-22
JPS4899179A (ja) 1973-12-15
PL92117B1 (ja) 1977-03-31
SU464111A3 (ru) 1975-03-15
AT324335B (de) 1975-08-25
SU468416A3 (ru) 1975-04-25
AU5287673A (en) 1975-03-27
CH579049A5 (ja) 1976-08-31
DE2210672C3 (de) 1980-03-20
CA1045138A (en) 1978-12-26
SU470958A3 (ru) 1975-05-15
NL7303135A (ja) 1973-09-10
FR2183674A1 (ja) 1973-12-21
AU468879B2 (en) 1975-03-27
US3883540A (en) 1975-05-13
SU466656A3 (ru) 1975-04-05
KR780000010B1 (en) 1978-03-04
ZA731500B (en) 1973-11-28
ES412319A1 (es) 1976-05-01
DD107456A5 (ja) 1974-08-05
GB1384031A (en) 1975-02-19
DK136900B (da) 1977-12-12
IE37366B1 (en) 1977-07-06
CS173649B2 (ja) 1977-02-28
IL41668A (en) 1977-02-28
DE2210672B2 (de) 1979-07-12
ES439487A1 (es) 1977-02-01
RO62798A (fr) 1977-11-15
SU457217A3 (ru) 1975-01-15
PL89257B1 (ja) 1976-11-30
BG20351A3 (bg) 1975-11-05
SU451241A3 (ru) 1974-11-25

Similar Documents

Publication Publication Date Title
DK136900C (da) Analogifremgangsmaade til fremstilling af usymmetriske 1,4-dihydropyridindicarboxylsyreestere
DK132496C (da) Analogifremgangsmade til fremstilling af usymmetriske 1,4-dihydropyridincarboxylsyreestere
DK137753C (da) Analogifremgangsmaade til fremstilling af basiske 1,4-dihydropyridincarboxylsyreestere
DK133158C (da) Analogifremgangsmade til fremstilling af 3-oxo-17alfa-acyloxyandrost-4-en-17beta-carboxylsyreestere
NO142397C (no) Analogifremgangsmaate for fremstilling av 6,11-dihydro-11-oksodibenz (b,e)-oksepineddiksyrer
DK137722C (da) Analogifremgangsmaade til fremstilling af dihydropyridin-polyestere
DK134600C (da) Fremgangsmade til fremstilling af usymmetriske 1,4-dihydropyridindicarboxylsyreestere
DK139361C (da) Analogifremgangsmaade til fremstilling af 17alfa-hydroxy-3,20-dioxo-4-pregnen-21-syrer
SE428692B (sv) Forfarande for framstellning av 7beta-amino-3-cefem-4-karboxylsyraforeningar
DK133977B (da) Fremgangsmåde til fremstilling af 2-chlor-5-sulfamoylbenzoesyrer.
SE385883B (sv) Forfarande for framstellning av nya pyridinkarbonsyraestrar
SE418176B (sv) Forfarande for framstellning av substituerade indanettiksyror
DK135380B (da) Analogifremgangsmade til fremstilling af pregnan-21-syrederivater
DK131864C (da) Fremgangsmade til fremstilling af pregnan-21-syrederivater
DK132273C (da) Fremgangsmade til fremstilling af trans-chrysanthemsyre
DK130976B (da) Fremgangsmåde til fremstilling af 2,5-dimethyl-furan-3-carboxylsyreestere.
DK133667B (da) Fremgangsmåde til fremstilling af 5-cyklohexyl-6-halogenindan-1-karboxylsyrederivater.
DK133297C (da) Analogifremgangsmade til fremstilling af 6-halogen-6-cyklohexylindan-1-karbohydroxamsyre
DK138693C (da) Fremgangsmaade til fremstilling af 0,0-dialkyl-0-(2,2-dichlorvinyl)-thionphosphorsyreestere
DK134155B (da) Analogifremgangsmåde til fremstilling af 2,2-diaryl-cyclopropancarboxylsyre-estere.
SE391715B (sv) Forfarande for framstellning av nya, substituerade fenylettiksyraestrar
NL7409878A (nl) Fenylboterzuurglycerylesters.
DK132658C (da) Fremgangsmade til fremstilling af sorbinsyre
DK138450B (da) Fremgangsmåde til fremstilling af arylamino-2-imidazoliner og syreadditionssalte deraf.
DK137008B (da) Analogifremgangsmade til fremstilling af syreamider

Legal Events

Date Code Title Description
PBP Patent lapsed